五味通便茶联合复方聚乙二醇电解质散在功能性便秘患者结肠镜检查前肠道准备中的效果观察

黄士财, 方东, 韩素芬, 等. 五味通便茶联合复方聚乙二醇电解质散在功能性便秘患者结肠镜检查前肠道准备中的效果观察[J]. 中国中西医结合消化杂志, 2024, 32(9): 811-815. doi: 10.3969/j.issn.1671-038X.2024.09.13
引用本文: 黄士财, 方东, 韩素芬, 等. 五味通便茶联合复方聚乙二醇电解质散在功能性便秘患者结肠镜检查前肠道准备中的效果观察[J]. 中国中西医结合消化杂志, 2024, 32(9): 811-815. doi: 10.3969/j.issn.1671-038X.2024.09.13
HUANG Shicai, FANG Dong, HAN Sufen, et al. Observation on the effect of Wuwei Tongbian tea combined with compound polyethylene glycol electrolyte powder in bowel preparation prior to colonoscopy in patients with functional constipation[J]. Chin J Integr Tradit West Med Dig, 2024, 32(9): 811-815. doi: 10.3969/j.issn.1671-038X.2024.09.13
Citation: HUANG Shicai, FANG Dong, HAN Sufen, et al. Observation on the effect of Wuwei Tongbian tea combined with compound polyethylene glycol electrolyte powder in bowel preparation prior to colonoscopy in patients with functional constipation[J]. Chin J Integr Tradit West Med Dig, 2024, 32(9): 811-815. doi: 10.3969/j.issn.1671-038X.2024.09.13

五味通便茶联合复方聚乙二醇电解质散在功能性便秘患者结肠镜检查前肠道准备中的效果观察

  • 基金项目:
    北京医学奖励基金(No:YXJK-2020-1320-0764);吴崑岚名中医工作室(No:2023-NJSMZYGZS-WKL);昆山市中西医结合医院科技项目(No:KZXY202301)
详细信息

Observation on the effect of Wuwei Tongbian tea combined with compound polyethylene glycol electrolyte powder in bowel preparation prior to colonoscopy in patients with functional constipation

More Information
  • 目的 探究五味通便茶联合复方聚乙二醇电解质散(compound polyethylene glycol electrolyte powder,PEG)对功能性便秘肠道准备的效果。方法 选取昆山市中西医结合医院2022年1月—2024年1月行结肠镜检查的480例功能性便秘患者为研究对象。对照组(n=233例)将3盒PEG加入3 000 mL温水中,分次口服。观察组(n=247例)在对照组基础上提前1 d取五味通便茶泡饮。记录两组患者的肠道清洁度、气泡情况、用药方案接受度、息肉检出率及安全性。结果 观察组患者肠道清洁度Boston肠道准备量表评分优于对照组(P < 0.01),恶心呕吐、腹胀的发生率低于对照组(P < 0.01),用药方案接受度明显高于对照组(P < 0.01)。结论 五味通便茶联合PEG在功能性便秘患者肠道准备中的效果优于单纯使用PEG,肠道清洁度更高,不良反应少,患者更易接受,具有一定的临床推广价值。
  • 加载中
  • 表 1  两组患者肠道清洁评分、气泡评分及方案接受度的比较 分,X±S

    观察指标 对照组(n=233) 观察组(n=247) t P
    BBPS评分 6.936±0.731 8.328±0.813 -19.754 0.003
      左半结肠 1.953±0.362 2.842±0.376 -26.371 0.002
      中段结肠 2.232±0.433 2.765±0.434 -13.471 0.003
      右半结肠 2.751±0.443 2.721±0.450 0.746 0.456
    气泡评分 16.618±1.431 16.725±1.519 -0.791 0.429
      直肠 2.712±0.490 2.769±0.422 -1.356 0.176
      乙状结肠 2.082±0.628 2.134±0.586 -0.939 0.348
      降结肠 2.305±0.735 2.364±0.719 -0.899 0.369
      横结肠 2.927±0.261 2.879±0.351 1.724 0.085
      升结肠 1.966±0.694 2.020±0.683 -0.868 0.386
      回盲部 2.639±0.490 2.563±0.497 1.703 0.089
      回肠末端 1.987±0.173 1.996±0.110 -0.670 0.503
    方案接受度 1.305±0.471 1.874±0.388 -14.421 0.006
    下载: 导出CSV

    表 2  两组患者的结肠息肉检出情况比较 

    组别 例数 息肉直径/cm 检出率/%
    < 0.5 0.5~1.0 >1.0
    对照组 233 24 37 15 32.618
    观察组 247 22 36 12 28.340
    χ2 1.224 1.037
    P 0.747 0.309
    下载: 导出CSV

    表 3  两组患者肠道准备用药后安全性评价比较 分,X±S

    组别 例数 恶心呕吐 腹胀 腹痛 头晕头痛 口干 乏力
    对照组 233 1.845±0.374 1.691±0.481 0.734±0.443 0.781±0.414 0.702±0.375 0.843±0.536
    观察组 247 0.931±0.382 0.972±0.427 0.700±0.485 0.709±0.464 0.721±0.483 0.852±0.649
    t 26.508 17.286 0.791 1.810 0.526 0.563
    P 0.003 0.007 0.429 0.071 0.468 0.453
    下载: 导出CSV

    表 4  两组患者肠道准备用药后电解质情况比较 mmol/L,X±S

    组别 例数 血钠 血钾 血镁 血氯
    对照组 198 136.34±0.25 4.68±0.37 0.79±0.58 106.35±0.59
    观察组 215 141.47±0.14 4.56±0.52 0.82±0.38 104.28±0.65
    t 23.425 3.576 0.368 34.785
    P 0.258 0.127 0.096 0.068
    下载: 导出CSV
  • [1]

    Tamai N, Adachi S, Sumiyama K. Bowel preparation for improving the quality of colonoscopy[J]. Dig Endosc, 2022, 34(6): 1134-1135. doi: 10.1111/den.14339

    [2]

    中国医师协会内镜医师分会消化内镜专业委员会, 中国抗癌协会肿瘤内镜学专业委员会. 中国消化内镜诊疗相关肠道准备指南(2019, 上海)[J]. 中华消化内镜杂志, 2019, 36(7): 457-469. doi: 10.3760/cma.j.issn.1007-5232.2019.07.001

    [3]

    Shahini E, Sinagra E, Vitello A, et al. Factors affecting the quality of bowel preparation for colonoscopy in hard-to-prepare patients: Evidence from the literature[J]. World J Gastroenterol, 2023, 29(11): 1685-1707. doi: 10.3748/wjg.v29.i11.1685

    [4]

    Rosa B, Andrade P, Lopes S, et al. Pan-Enteric Capsule Endoscopy: Current Applications and Future Perspectives[J]. GE Port J Gastroenterol, 2024, 31(2): 89-100. doi: 10.1159/000533960

    [5]

    Aziz I, Whitehead WE, Palsson OS, et al. An approach to the diagnosis and management of Rome Ⅳ functional disorders of chronic constipation[J]. Expert Rev Gastroenterol Hepatol, 2020, 14(1): 39-46. doi: 10.1080/17474124.2020.1708718

    [6]

    Lorenzo CD, Khlevner J, Rodriguez-Araujo G, et al. Efficacy and safety of linaclotide in treating functional constipation in paediatric patients: a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial[J]. Lancet Gastroenterol Hepatol, 2024, 9(3): 238-250. doi: 10.1016/S2468-1253(23)00398-9

    [7]

    Chen Z, Peng YY, Shi QY, et al. Prevalence and Risk Factors of Functional Constipation According to the Rome Criteria in China: A Systematic Review and Meta-Analysis[J]. Front Med(Lausanne), 2022, 9: 815156.

    [8]

    Todhunter-Brown A, Booth L, Campbell P, et al. Strategies used for childhood chronic functional constipation: the SUCCESS evidence synthesis[J]. Health Technol Assess, 2024, 28(5): 1-266.

    [9]

    Vilanova-Sanchez A, Levitt MA. Surgical Interventions for Functional Constipation: An Update[J]. Eur J Pediatr Surg, 2020, 30(5): 413-419. doi: 10.1055/s-0040-1716729

    [10]

    Tan C, Qin G, Wang QQ, et al. Clinicopathologic and endoscopic features of sessile serrated lesions and conventional adenomas: a large inpatient population-based study in China[J]. Front Oncol, 2024, 14: 1337035. doi: 10.3389/fonc.2024.1337035

    [11]

    Li X, Hu M, Wang ZJ, et al. Prevalence of diverse colorectal polyps and risk factors for colorectal carcinoma in situ and neoplastic polyps[J]. J Transl Med, 2024, 22(1): 361. doi: 10.1186/s12967-024-05111-z

    [12]

    Fuccio L, Collatuzzo G, Frazzoni L, et al. Impact of colonoscopy on working productivity: a prospective multicenter observational study[J]. Gastrointest Endosc, 2022, 95(3): 550-561. doi: 10.1016/j.gie.2021.11.039

    [13]

    Hassan C, East J, Radaelli F, et al. Bowel preparation for colonoscopy: European Society of Gastrointestinal Endoscopy(ESGE)Guideline-Update 2019[J]. Endoscopy, 2019, 51(8): 775-794. doi: 10.1055/a-0959-0505

    [14]

    Xiong Z, Fang Y, Feng FF, et al. 2 L polyethylene glycol combined with castor oil versus 4 L polyethylene glycol for bowel preparation before colonoscopy among inpatients[J]. Medicine(Baltimore), 2023, 102(29): e34294.

    [15]

    唐萍, 毕梅, 邹绍静, 等. 再次口服缓泻剂与清洁灌肠对普通结肠镜检查肠道准备不充分患者补救效果的对比研究[J]. 中国内镜杂志, 2020, 26(5): 15-19. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGNJ202005004.htm

    [16]

    Yang HJ, Park DI, Park SK, et al. A Randomized Controlled Trial Comparing Colonoscopic Enema With Additional Oral Preparation as a Salvage for Inadequate Bowel Cleansing Before Colonoscopy[J]. J Clin Gastroenterol, 2019, 53(8): e308-e315. doi: 10.1097/MCG.0000000000001087

    [17]

    梁浩杰, 钱海华, 陈丹. 番泻叶治疗便秘作用机制的研究进展[J]. 齐齐哈尔医学院学报, 2023, 44(20): 1946-1950. doi: 10.3969/j.issn.1002-1256.2023.20.010

    [18]

    刘畅, 王潇, 刘芳, 等. 厚朴酚对便秘型肠易激综合征大鼠5-HT通路及肠道菌群的影响[J]. 中成药, 2023, 45(9): 3067-3072. doi: 10.3969/j.issn.1001-1528.2023.09.044

    [19]

    荆文光, 赵小亮, 常潞, 等. 基于血清药物化学和网络药理学的厚朴"下气除满"药效物质基础和作用机制研究[J]. 中国现代中药, 2022, 24(4): 652-664. https://www.cnki.com.cn/Article/CJFDTOTAL-YJXX202204014.htm

    [20]

    贾蔷, 阴启明, 李运伦, 等. 莱菔子化学成分及药理作用研究概况[J]. 山东中医药大学学报, 2023, 47(6): 805-811. https://www.cnki.com.cn/Article/CJFDTOTAL-SDYX202306020.htm

    [21]

    Maeda N, Higashimori A, Nakatani M, et al. Efficacy and tolerability of 1 L polyethylene glycol plus ascorbic acid with senna versus 2 L polyethylene glycol plus ascorbic acid for colonoscopic bowel preparation: Prospective, randomized, investigator-blinded trial[J]. Dig Endosc, 2023, 35(6): 767-776. doi: 10.1111/den.14504

    [22]

    覃玉娜, 杜金杰, 吴新惠, 等. 茶对焦虑与抑郁的缓解作用研究进展[J]. 食品研究与开发, 2023, 44(21): 214-219. doi: 10.12161/j.issn.1005-6521.2023.21.030

    [23]

    Rajindrajith S, Ranathunga N, Jayawickrama N, et al. Behavioral and emotional problems in adolescents with constipation and their association with quality of life[J]. PLoS One, 2020, 15(10): e0239092. doi: 10.1371/journal.pone.0239092

    [24]

    王慧, 钟国跃, 张寿文, 等. 枳壳化学成分、药理作用的研究进展及其质量标志物的预测分析[J]. 中华中医药学刊, 2022, 40(9): 184-192, 284. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYHS202209041.htm

    [25]

    张明发, 沈雅琴. 厚朴酚及和厚朴酚抗抑郁药理作用及机制的研究进展[J]. 药物评价研究, 2024, 47(2): 450-456. https://www.cnki.com.cn/Article/CJFDTOTAL-YWPJ202402024.htm

  • 加载中
计量
  • 文章访问数:  662
  • PDF下载数:  314
  • 施引文献:  0
出版历程
收稿日期:  2024-05-12
刊出日期:  2024-09-15

目录